Concert Pharma Drops On Patent Litigation Setback; Mizuho Downgrades
January 12, 2018 at 13:48 PM EST
Concert Pharmaceuticals Inc (NASDAQ: CNCE) announced Friday the Patent Trial and Appeal Board decided not to grant the company a Post ...